# ImmunityBio, Inc.: Form 8-K, filed Mar 17, 2021

- Company: [ImmunityBio, Inc.](/companies/ibrx.md) (CIK 1326110)
- Form: 8-K
- Filed: 2021-03-17
- Accepted by EDGAR: Mar 17, 2021, 17:24 ET
- Period: 2021-03-17
- Accession: 0001193125-21-084244
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1326110/000119312521084244/d159616d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326110/000119312521084244/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326110/000119312521084244/d159616d8k.htm

Filed Mar 17, 2021.
Source: SEC EDGAR, the filing index for accession 0001193125-21-084244. Last ingested by Listed: Nov 9, 2026, 17:45 ET. No prices; not investment advice.
